These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11831074)

  • 21. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
    Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morbidity and mortality data associated with ESRD and dialysis: should patients be informed? The "truth," the whole truth, and nothing but the truth... informing ESRD patients of their prognoses.
    Miller RB
    Nephrol Nurs J; 2005; 32(4):441-2. PubMed ID: 16180786
    [No Abstract]   [Full Text] [Related]  

  • 23. Uses and abuses of screening tests.
    Grimes DA; Schulz KF
    Lancet; 2002 Mar; 359(9309):881-4. PubMed ID: 11897304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT screening: a trade-off of risks, benefits, and costs.
    Hunink MG; Gazelle GS
    J Clin Invest; 2003 Jun; 111(11):1612-9. PubMed ID: 12782661
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical research: why trouble the patient for informed consent?
    Farnell SM
    Med Pediatr Oncol; 2002 Sep; 39(3):207-9; discussion 210-1. PubMed ID: 12210453
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cancer screening: medico-legal aspects].
    Buzzi F
    Ann Ig; 2003; 15(1):3-10. PubMed ID: 12666320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
    Andersen SB; Vejborg I; von Euler-Chelpin M
    Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "It ain't easy being green," a case-based analysis of ethics and medical education on the wards.
    Bonomo JB; Rinderknecht TN; Beiser EN
    Med Health R I; 2003 Sep; 86(9):276-8. PubMed ID: 14556410
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of HIV rapid tests in free and anonymous screening consultations in the French West Indies].
    Cabié A; Bissuel F; Abel S; Huc P; Paturel L; Pierre-François S
    Med Mal Infect; 2009 Jun; 39(6):370-4. PubMed ID: 19346089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thoughts about the 'informed consent'].
    Riskó T
    Orv Hetil; 2005 Jan; 146(5):236-7; author reply 238-9; discussion 239. PubMed ID: 15773593
    [No Abstract]   [Full Text] [Related]  

  • 31. The informed consent doctrine. A defined responsibility.
    Arnold T
    N J Med; 2002 Apr; 99(4):24-31. PubMed ID: 11977777
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ethical and documentary demands for preventive medicine and screening].
    Riis P
    Ugeskr Laeger; 1978 Oct; 140(40):2457-8. PubMed ID: 695095
    [No Abstract]   [Full Text] [Related]  

  • 33. Should nurses give medication without the patient's consent?
    Nicholls J; Clayton H
    Nurs Times; 2001 Oct 11-17; 97(41):17. PubMed ID: 11966014
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening instruments for delirium in older people with an acute medical illness.
    Yates C; Stanley N; Cerejeira JM; Jay R; Mukaetova-Ladinska EB
    Age Ageing; 2009 Mar; 38(2):235-7. PubMed ID: 19110484
    [No Abstract]   [Full Text] [Related]  

  • 35. Insurance MDs want to make informed consent about HIV screening more informed.
    CMAJ; 1990 Sep; 143(5):414-5. PubMed ID: 2390756
    [No Abstract]   [Full Text] [Related]  

  • 36. Morbidity and mortality data associated with ESRD and dialysis: should patients be informed? Giving hope through information.
    Nelson M
    Nephrol Nurs J; 2005; 32(4):440-1. PubMed ID: 16180785
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical issues in the evaluation of screening and early detection modalities.
    Etzioni R
    Urol Oncol; 2008; 26(3):308-15. PubMed ID: 18452826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass screening: theory and ethics.
    Mant D; Fowler G
    BMJ; 1990 Apr; 300(6729):916-8. PubMed ID: 2110841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are there downsides to mammography screening?
    Baines CJ
    Breast J; 2005; 11 Suppl 1():S7-10. PubMed ID: 15725116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.